Listen to this article
Estimated 2 minutes
The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results.
Health Canada has authorized Moderna’s mRNA vaccine for influenza, as well as its combination mRNA vaccine for flu and COVID-19.
Both are approved for adults 50 years of age and older.
Moderna told The Canadian Press they will not hit pharmacies in time for this respiratory virus season.
The National Advisory Committee on Immunization recommends that everyone six months of age and older get the non-mRNA flu shot that’s available this year.
A higher-dose version of the flu vaccine is recommended for adults aged 65 and older because aging immune systems often need a bigger boost.
The committee also strongly advises COVID-19 vaccination for anyone 65 years of age and older and residents of long-term care, retirement homes or assisted living.
Moderna and Pfizer both have mRNA COVID-19 vaccines available in Canada this year.
The U.S. FDA has approved the first mRNA flu vaccine, from Moderna, for Americans 50 and older. While studies suggest it could be significantly more effective than traditional flu shots, Health Canada is still reviewing it.
A spokesperson for Moderna said Health Canada notified the company that its flu vaccine (called mFLUSIVA) and its combination flu and COVID-19 shot (called mCOFLU) were approved on Thursday.
In a news release, the company said its mRNA flu shot was approved in the United States in August and that its combination vaccine was approved in Europe last April.
It said Canada is the first country to authorize both vaccines.
